Kidney In Vitro Platform Overview
Learn how our integrated in vitro nephrology platform supports every stage of kidney research, from high-throughput screening to advanced disease modeling. This brochure highlights our available renal models, experimental strategies, and application scenarios for preclinical drug discovery.
Download the brochure to discover the most suitable in vitro kidney models for your research and accelerate nephrology drug discovery with physiologically relevant experimental platforms.
Robust ischemia-reperfusion and cisplatin-induced AKI in C57BL/6 mice with validated injury biomarkers.
Translational AKI platforms covering ischemic, nephrotoxic, and sepsis-induced injury across multiple species.
Transgenic human CD89/hIGHA1 mice recapitulating spontaneous mesangial IgA deposition and podocyte injury.
Comprehensive IgA nephropathy panel including humanized, active immunization, and lectin-induced models for therapeutic evaluation.
Ace Therapeutics has a group of highly committed and skilled researchers with the objective to provide innovative preclinical contract research solutions to cope with kidney diseases.
We strives to accelerate the development of innovative therapies that address unmet medical needs.
Copyright © Ace Therapeutics. All rights reserved.
↑